Corton Capital’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,103	Closed	-$204K	–	334
2022 Q3	$204K	Buy	9,103 +175	+2%	+$3.92K	0.25%	191
2022 Q2	$221K	Buy	8,928 +452	+5%	+$11.2K	0.21%	206
2022 Q1	$329K	Buy	+8,476	New	+$329K	0.14%	204